Dexcom Inc at Piper Sandler Ophthalmology and Diabetes Symposium (Virtual) Transcript
' -
Good afternoon, everybody. It's Matt O'Brien from Piper's MedTech research team on here with you. Thanks for joining our Annual Diabetes Day conference. We're really excited to have DexCom on with us. From the company is Brice Bobzien, the Senior Vice President of Finance. I think Sean and Matt are kind of in the background as well, listening in.
Format of the call is going to be pretty typical. A bunch of questions from me. This is an interactive session, so please do use the Q&A feature at the bottom of the Zoom, if you have questions, or just e-mail me, and I'm happy to ask those questions on your behalf. It's [email protected].
And with those comments out of the way, let's go ahead and get started. Brice, thanks again for the time here today. Really appreciate you hopping on with us.
Of course, Matt, thanks so much for having us. I appreciate the opportunity.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |